Indication

Actinic keratosis

Actinic keratosis, also referred to as solar keratosis, is a common premalignant cutaneous neoplasm that arises within the epidermis due to cumulative ultraviolet radiation exposure. Read more about Actinic keratosis

54 drugs 34 manufacturers

Advertisement

Drugs that treat it

Common Actinic keratosis therapies.

Showing 1–9 of 54 drugs

IMIQUIMOD

EXTERNAL CONDYLOMATA ACUMINATA·+2
SANDOZ

FLUOROURACIL

SUPERFICIAL BASAL CELL CARCINOMA·+1
OCEANSIDE PHARM

FLUOROURACIL

ACTINIC KERATOSES AGENTS·SUPERFICIAL BASAL CELL CARCINOMA·+1
Mylan Pharmaceuticals

FLUOROURACIL

SUPERFICIAL BASAL CELL CARCINOMA·+1
SPEAR DERM PROD
Filter & compare in the drug finder →Opens the drug finder with Actinic keratosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Actinic keratosis.

Actinic keratosis, also referred to as solar keratosis, is a common premalignant cutaneous neoplasm that arises within the epidermis due to cumulative ultraviolet radiation exposure.

The condition predominantly affects fair-skinned, older, or immunocompromised individuals across chronically sun-exposed anatomical sites such as the face, scalp, ears, forearms, and dorsal hands.

Clinically, lesions present as rough, gritty, erythematous, or hyperkeratotic papules and plaques.

Pathophysiologically, it is characterized by atypical keratinocyte proliferation, nuclear pleomorphism, and architectural disorganization within the epidermis, carrying an intrinsic potential to progress to invasive cutaneous squamous cell carcinoma.

Personalize your experience

Follow Actinic keratosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it